Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3134157 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
sphingosine kinase 1/Sphingosine kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4394] [GtoPdb: 2204] [UniProtKB: Q9NYA1] | ||||||||
ChEMBL | Binding affinity to SK1 (unknown origin) assessed as inhibition of sphingosine phosphorylation | B | 8.3 | pKd | 5 | nM | Kd | J Med Chem (2018) 61: 9811-9840 [PMID:29969256] |
ChEMBL | Inhibition of His6 tagged human SphK1 expressed in Sf21 cells using FITC-sphingosine as substrate preincubated for 90 mins prior substrate addition by Caliper assay | B | 8.37 | pKi | 4.3 | nM | Ki | ACS Med Chem Lett (2014) 5: 1329-1333 [PMID:25516793] |
ChEMBL | Inhibition of SK1 (unknown origin) | B | 8.4 | pKi | 4 | nM | Ki | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
GtoPdb | - | - | 8.44 | pKi | 3.6 | nM | Ki | Biochem J (2012) 444: 79-88 [PMID:22397330] |
ChEMBL | Inhibition of recombinant human C-terminal His-tagged SPHK1 expressed in fall armyworm sf21 cells using sphingosine as substrate after 1 hr by FITC-based caliper assay | B | 8.44 | pKi | 3.6 | nM | Ki | J Med Chem (2017) 60: 3933-3957 [PMID:28406646] |
ChEMBL | Inhibition of human C-terminal His6-tagged SphK1 expressed in baculovirus infected Sf21 insect cells | B | 8.44 | pKi | 3.6 | nM | Ki | Eur J Med Chem (2017) 139: 461-481 [PMID:28822281] |
ChEMBL | Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]SIP production using D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method | B | 8.44 | pKi | 3.6 | nM | Ki | Bioorg Med Chem (2021) 30: 115941-115941 [PMID:33385956] |
ChEMBL | Competitive inhibition of recombinant human C-terminal His-tagged SphK1 expressed in baculovirus infected Sf21 cells using varying concentrations of FITC-sphingosine as substrate incubated for 30 mins by LC-MS/MS analysis | B | 8.44 | pKi | 3.6 | nM | Ki | Eur J Med Chem (2020) 206: 112713-112713 [PMID:32919113] |
ChEMBL | Competitive-inhibition of recombinant human C-terminal His6-tagged Sphk1 expressed in baculovirus infected Sf21 insect cells using varying levels of sphingosine as substrate measured after 30 mins by LC-MS analysis | B | 8.44 | pKi | 3.6 | nM | Ki | Eur J Med Chem (2021) 212: 113121-113121 [PMID:33445156] |
ChEMBL | Inhibition of human recombinant SphK1 expressed in Sf9 cells assessed as radiolabeled products using 5 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting | B | 8.44 | pKi | 3.6 | nM | Ki | J Med Chem (2015) 58: 1879-1899 [PMID:25643074] |
ChEMBL | Inhibition of recombinant His-tagged human SK1 assessed as production of [32P]-S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP | B | 6.41 | pIC50 | 387 | nM | IC50 | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
ChEMBL | Inhibition of SphK1 (unknown origin) | B | 7.4 | pIC50 | 40 | nM | IC50 | Bioorg Med Chem Lett (2021) 34: 127754-127754 [PMID:33347967] |
ChEMBL | Inhibition of recombinant SK1 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins | B | 7.55 | pIC50 | 28 | nM | IC50 | Medchemcomm (2013) 4: 1394-1399 [PMID:24396570] |
ChEMBL | Inhibition of SK1 (unknown origin) using 5 uM of sphingosine as substrate | B | 7.55 | pIC50 | 28 | nM | IC50 | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
ChEMBL | Inhibition of GFP-tagged SK1 (unknown origin) expressed in HEK293 cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis | B | 7.55 | pIC50 | 28 | nM | IC50 | J Med Chem (2019) 62: 3658-3676 [PMID:30889352] |
ChEMBL | Inhibition of SPHK1 in human whole-blood using C17-sphingosine as substrate assessed as reduction in C17-S1P production preincubated for 30 mins followed by substrate addition measured after 10 mins by MS analysis | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
ChEMBL | Inhibition of SK1 (unknown origin) using 3 uM of sphingosine as substrate | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
ChEMBL | Inhibition of recombinant C-terminal His6-tagged human SphK1 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay | B | 8.57 | pIC50 | 2.7 | nM | IC50 | Bioorg Med Chem (2017) 25: 3046-3052 [PMID:28408190] |
ChEMBL | Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in S1P formation using sphingosine as substrate after 1 hr by FITC-based caliper assay | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
GtoPdb | - | - | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
ChEMBL | Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in ADP formation using sphingosine as substrate preincubated for 15 mins followed by substrate addition after 1 hr by transcreener-based fluorescence polarization assay | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
GtoPdb | - | - | 8.7 | pIC50 | 2 | nM | IC50 | Biochem J (2012) 444: 79-88 [PMID:22397330] |
ChEMBL | Inhibition of SPHK1 in human MDA1483 cells using C17-sphingosine as substrate assessed as reduction in C17-S1P formation preincubated for 30 mins with substrate measured after 15 mins by LC-MS analysis | B | 9.1 | pIC50 | 0.8 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
sphingosine kinase 1/Sphingosine kinase 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2401605] [GtoPdb: 2204] [UniProtKB: Q8CI15] | ||||||||
ChEMBL | Inhibition of SphK1 in mouse erythrocytes using sphingosine as substrate by luminescence assay | B | 8.44 | pKi | 3.6 | nM | Ki | ACS Med Chem Lett (2016) 7: 229-234 [PMID:26985306] |
sphingosine kinase 2/Sphingosine kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3023] [GtoPdb: 2205] [UniProtKB: Q9NRA0] | ||||||||
ChEMBL | Inhibition of SK2 (unknown origin) | B | 8.44 | pKi | 3.6 | nM | Ki | J Med Chem (2019) 62: 3658-3676 [PMID:30889352] |
ChEMBL | Inhibition of recombinant human SK2 assessed as production of [32P] S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP relative to control | B | 4.77 | pIC50 | 17000 | nM | IC50 | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
ChEMBL | Inhibition of SK2 (unknown origin) | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
ChEMBL | Inhibition of SphK2 (unknown origin) | B | 5.27 | pIC50 | 5400 | nM | IC50 | Bioorg Med Chem Lett (2021) 34: 127754-127754 [PMID:33347967] |
ChEMBL | Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis | B | 5.3 | pIC50 | >5000 | nM | IC50 | J Med Chem (2019) 62: 3658-3676 [PMID:30889352] |
ChEMBL | Inhibition of human recombinant C-terminal His6 tagged SphK2 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay | B | 6.44 | pIC50 | 360 | nM | IC50 | Bioorg Med Chem (2017) 25: 3046-3052 [PMID:28408190] |
ChEMBL | Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay | B | 6.45 | pIC50 | 356 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
GtoPdb | - | - | 6.45 | pIC50 | 356 | nM | IC50 | J Med Chem (2017) 60: 2562-2572 [PMID:28231433] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]